Biopharmaceutical News and Research

RSS
Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Porter Alliance for Innovative Medicines aims to close the gap between scientific research and clinical care

Porter Alliance for Innovative Medicines aims to close the gap between scientific research and clinical care

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

NeoCura and PhoreMost Announce Research Collaboration   to Explore Novel Cancer Therapeutics

NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Optimizing bioprocessing with Raman spectroscopy

Optimizing bioprocessing with Raman spectroscopy

Driving up immunity at tumor site may help enhance immunotherapy treatments

Driving up immunity at tumor site may help enhance immunotherapy treatments

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Protein found in rattlesnake venom used for making a drug candidate to modulate blood clotting

Protein found in rattlesnake venom used for making a drug candidate to modulate blood clotting

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Waters and Sartorius partner to help bioprocess scientists accelerate clone selection and process development

Waters and Sartorius partner to help bioprocess scientists accelerate clone selection and process development

Interferon beta-1a plus remdesivir not superior to remdesivir alone in hospitalized COVID-19 patients

Interferon beta-1a plus remdesivir not superior to remdesivir alone in hospitalized COVID-19 patients

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

New Maternal and Child Health Research Institute launched to improve national health in Singapore

New Maternal and Child Health Research Institute launched to improve national health in Singapore

Experts address questions on psoriasis patients’ true needs and wellbeing

Experts address questions on psoriasis patients’ true needs and wellbeing

RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program

RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.